NuGen files two patent applications for needle-free drug delivery technology

PUBT · 1d ago
NuGen files two patent applications for needle-free drug delivery technology
  • NuGen Medical Devices filed two patent applications on July 27, 2026, adding to its needle-free drug delivery intellectual property portfolio.
  • Filings cover high-efficiency spring charging and automatic dose-setting technologies aimed at simplifying use and improving consistency versus the InsuJet platform.
  • Applications support development of NuGen’s planned Transfer, Refill, and Prefilled needle-free platform family.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NuGen Medical Devices Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607271715NEWSFILECNPR____20260727_306767_1) on July 27, 2026, and is solely responsible for the information contained therein.